ACRC Building

HYPOACTIVE SEXUAL DESIRE DISORDER IN SURGICALLY MENOPAUSAL WOMEN

Summary: This is an 8-month clinical research study to assess the safety and effectiveness of an investigational (not approved by the FDA) drug for women who have had their ovaries removed and have since experienced a decline in sexual desire, a condition call Hypoactive Sexual Desire Disorder (HSDD).

Participation qualifications:

Benefits:

Study participants may receive study-related medical examinations, laboratory testing, and study medication or a placebo (an inactive substance).

Compensation up to $450.00 for time and travel is also available.

If you are interested in this study, please contact:
 
ACRC/Arizona Clinical Research Center, Inc.
1825 N. Kolb Rd.
Tucson, AZ 85715
Phone: (520) 290-9896
Fax: (520) 290-2508

Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening, and have been fully evaluated at the study site.


Return Home